Overview

Clinical Study of Desmoteplase in Japanese Patients With Acute Ischemic Stroke

Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate whether desmoteplase is safe and tolerated when given to Japanese patients with acute ischemic stroke
Phase:
Phase 2
Details
Lead Sponsor:
Lundbeck Japan K. K.
Treatments:
Salivary plasminogen activator alpha 1, Desmodus rotundus